Easton Pharmaceuticals (OP: EAPH) Signs LOI to Acquire a Cosmetic Anti-Aging and Beauty Care Line of Products Including a Product to Compliment its Medical Marijuana Initiatives
9/27/2013 9:37:52 AM
TORONTO--(BUSINESS WIRE)--Easton Pharmaceuticals, Inc. (OTC: EAPH) a specialty pharmaceutical company that designs, develops, and markets a premium array of topically-delivered therapeutic healthcare products, today announces it has signed a letter of intent to acquire a line of Anti-Ageing and beauty care products.
Help employers find you! Check out all the jobs and post your resume.
comments powered by